We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Shareholders in Incannex Healthcare (ASX: IHL) (NASDAQ: IXHL) have voted overwhelmingly in favour of...
Read ArticleSeveral ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their...
Read ArticleThe US is about to follow Australia’s footsteps and approve psychedelics The FDA is currently await...
Read ArticleIncannex subsidiary Psychennex prepares investigational new drug application for US FDA Application...
Read ArticleIncannex Healthcare (IHL) is charging ahead with another US application for an IND through its subs...
Read ArticleIncannex Healthcare (ASX: IHL) subsidiary Psychennex Pty Ltd has started preparing an investigationa...
Read ArticleClinical-stage pharmaceutical company Incannex Healthcare (ASX: IHL) has received approval from the...
Read ArticleIncannex Healthcare’s (IHL) subsidiary, Clarion Clinics Group, is initiating recruitment for subject...
Read ArticleIncannex Healthcare’s (ASX: IHL) subsidiary, Clarion Clinics Group, has begun accepting registration...
Read ArticleIncannex Healthcare has completed a constructive pre-Investigational New Drug Application (pre-IND)...
Read ArticleIncannex Healthcare (IHL) completes a pre-IND application meeting with the US FDA for its drug produ...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Incannex Healthcare (ASX: I...
Read ArticleIncannex Healthcare (ASX: IHL) has completed a pre-investigational new drug (pre-IND) application me...
Read ArticleIncannex Healthcare has successfully submitted an Investigational New Drug (IND) application to the...
Read ArticleWhat a time to be alive. As the clock struck midnight to herald the start of the 23/24 financial yea...
Read ArticleIncannex Healthcare (IHL) submits an Investigational New Drug (IND) application to the US Food and D...
Read ArticleThis content is created by Smallcaps Authors. [Author : Colin Hay] Clinical-stage pharmaceutical c...
Read ArticlePYC Therapeutics to advance to Phase 2 clinical trial Osteopore announced new CEO and non-executive...
Read ArticleIncannex has engaged Fortrea (NASDAQ: FTRE) as the contract research organisation (CRO) for manageme...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Incannex Healthcare (ASX: I...
Read ArticleIncannex has been given the green light to start its Phase 2 clinical trial to assess the safety and...
Read ArticleSocial media platforms are rushing to update their advertising policies on cannabis Meta was the mo...
Read ArticleIncannex Healthcare (IHL) receives approval from the Belberry Human Research Ethics Committee (HREC)...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is on the move on Thursday. In morning trade, th...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Medicinal cannabinoid and p...
Read ArticleIncannex Healthcare (ASX:IHL) has received approval from Bellberry Human Research Ethics Com...
Read ArticleThe ASX will rise once again after softer than expected CPI in the US Elon Musk announces new AI co...
Read ArticleSince TGA’s down-scheduling of CBD last year, no products have been sold in Australia But the race...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. In afternoon tr...
Read ArticleThis content is created by Smallcaps Authors. [Author : Colin Hay] Australian pharmaceutical canna...
Read ArticleBod Science provided a ‘landmark update’ on its Phase IIB insomnia clinical trial Neurotech receive...
Read ArticleThe days of Incannex Healthcare Ltd (ASX: IHL) shares trading on the ASX boards are now numbered. T...
Read ArticleIncannex Healthcare (IHL) receives ethics approval to commence a bioavailability/bioequivalence tria...
Read ArticleImricor jumps 13pc after securing $30m in funding Singular Health signs a master distribution agree...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Clinical-stage pharmaceutic...
Read ArticleIncannex is looking to replicate results from last year’s Phase-II proof of concept clinical trial o...
Read ArticleASX cannabis shares have had a tough year. Thatâs despite the fact that the cannabis stocks opera...
Read ArticleIt was only last month that we were discussing Incannex Healthcare Ltd (ASX: IHL) shares and the ep...
Read ArticleZelira announced that its diabetic nerve pain drug outperforms Pfizer’s Lyrica Diabetes is a huge m...
Read ArticleHighlights Incannex Healthcare Limited (ASX: IHL) is a clinical-stage pharmaceutical development...
Read ArticleThe ASX is tracking higher in midday trade, up six per cent. AGL Energy (AGL) is top of the pack on...
Read ArticleIncannex Healthcare has recruited two highly experienced lead principal investigators (PIs) for the...
Read ArticleIncannex Healthcare (IHL) recruits two principal investigators to lead a phase 2/3 clinical trial fo...
Read ArticleThis content is created by Smallcaps Authors. [Author : Colin Hay] Incannex Healthcare (ASX: IHL)...
Read ArticleThe world is experiencing a ‘shroom boom’ Psychedelics are expected to follow in cannabis’ explosiv...
Read ArticleIncannex Healthcare has announced that three of the world’s top psychedelic therapy and science expe...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Clinical stage pharmaceutic...
Read ArticleGot 90 seconds? Then listen to Director, Peter Widdows tell us about their company news. Medicinal c...
Read ArticleIncannex’s psychedelics focused subsidiary, Psychennex, believes that it has the best team of expert...
Read ArticleIt’s been a while since ASX cannabis stocks have been popular with ASX investors. They were all the...
Read ArticleStockhead’s In Case You Missed It highlights some of the strongest performing ASX stocks that might...
Read ArticleIncannex Healthcare’s subsidiary Clarion Clinics will be the first dedicated psychedelic-assisted ps...
Read ArticleThis content is created by Smallcaps Authors. [Author : Filip Karinja] Incannex Healthcare (ASX: I...
Read ArticleImpediMed gets clearance from the US FDA for its SOZO Pro bioimpedance spectroscopy SOZO Pro offers...
Read ArticleResults from a Phase-1 clinical of Incannex’s anti-inflammatory drug IHL-675A in healthy volunteers...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Clinical-stage psychedelic...
Read ArticleThe All Ordinaries Index (ASX: XAO) is having a rough session on Thursday, but two stocks are defyi...
Read ArticleThe S&P ASX 200 closed 0.35% lower, while the S&P XEC closed down 0.59% following lead of U...
Read ArticleThe 420 Day is unofficially the World Marijuana Day, and we look at the possible origins of this da...
Read ArticleIncannex has made a key appointment as it works to advance its CannQuit-N (Nicotine), CannQuitO (Opi...
Read ArticleIncannex (IHL) appoints Quest Pharmaceutical Services (QPS) to provide regulatory advice and manage...
Read ArticleThe Swiss government has moved quickly to shore up its uniqueness as a centre of commerce – albeit o...
Read ArticleIHL is undergoing a pivotal point in its journey as a company moving from pure research to service d...
Read ArticleIncannex Healthcare (IHL) announces plans to launch psychedelic-assisted psychotherapy clinics in Au...
Read ArticleThis content is created by Smallcaps Authors. [Author : Filip Karinja] Incannex Healthcare (ASX: I...
Read ArticleTelix Pharma gets FDA approval Prescient shows good data from Phase 1b clinical trial Incannex plan...
Read ArticleEven though specific data from the PsiGAD trial cannot yet be released until the trial is completed,...
Read ArticleIncannex Healthcare (IHL) projects its clinical trial will show a “statistically significant benefit...
Read ArticleThis content is created by Smallcaps Authors. [Author : Danica Cullinane] Incannex Healthcare (ASX...
Read ArticleTrading in ASX 300 cannabis stock Incannex Healthcare Ltd (ASX: IHL) has been suspended at the comp...
Read ArticleAussie bourse has worst day since November 3 with S&P ASX 200 down 2.28% Even darling lithium s...
Read ArticleASX cannabis stocks provide a valuable service to the many thousands of Australians who benefit fro...
Read ArticleShareCafeASX closes 0.4% higher but ends week 0.3% lower by Peter Milios At the closing bell, the...
Read ArticleASX 300 cannabis share Incannex Healthcare Ltd (ASX: IHL) is soaring today after the company announ...
Read ArticleIncannex Healthcare [ASX:IHL], the medical cannabis and psychedelic drug developer, released an upda...
Read Article03 Mar 2023 - A snapshot of the stocks on the move featuring Antilles Gold (ASX:AAU), Incannex (ASX:...
Read ArticleShareCafeStocks of the Hour: AAU, IHL, AGC Antilles Gold (ASX:AAU) has conf...
Read ArticleShareCafeASX 0.3% higher at noon after big gains from US stocks overnight by Peter Milios A day af...
Read ArticleIncannex Healthcare (IHL) engages NYSE-listed Catalent to manufacture a psilocybin drug product for...
Read ArticleAs Australia becomes the first country to recognise psychedelics as medicine, Incannex Healthcare is...
Read ArticleThis content is created by Smallcaps Authors. [Author : Lorna Nicholas] Incannex Healthcare (ASX:...
Read ArticleThe ASX is set to open higher on Friday, tracking overnight’s movement in New York Tesla dropped 6%...
Read ArticleHaving closed a $13 million placement in December for the development of its alternative medicine pi...
Read ArticleThe ASX slid to close flat today, after realising we were in danger of making some money Materials...
Read ArticleIncannex’ Phase-2 trial can potentially open the door to a US$125 billion market for the treatment o...
Read ArticleIncannex (IHL) kicks off a phase two trial of its IHL-675A drug to treat rheumatoid arthritis follow...
Read ArticleMedicinal cannabinoid and psychedelic medicine company Incannex Healthcare (ASX:IHL) has com...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Medicinal cannabinoid and p...
Read ArticleThe TGA has changed its classification of psilocybin and MDMA As a result, Australia has become the...
Read ArticleIndependent analysis has started of Incannex’s Phase 2 clinical trial to assess its psilocybin-assis...
Read ArticleIncannex Healthcare (IHL) achieves interim milestone in its clinical trial to treat generalised anxi...
Read ArticleThe ASX is set to drift higher at the open Goldman Sachs’ profit tumbled by 68pc The ECB is reporte...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Incannex Healthcare (ASX: I...
Read ArticleThe Australian legalisation of medical cannabis in 2016 launched a flood of new companies to the ASX...
Read ArticleASX Health sector has ended its upward trend falling 0.7% in the past five days in line with broade...
Read ArticleMedcan and psychedelic pharmaceutical company Incannex Healthcare (ASX: IHL) has filed a provisional...
Read ArticleIncannex Healthcare (IHL) has filed a provisional patent application for the use of IHL-42X for the...
Read ArticleIncannex Healthcare (IHL) has received firm commitments to raise $13 million through an institutiona...
Read ArticleASX 200 gets golden, adds 1% Small cap index rises 1.05% Greenstone finds yellow stone What you n...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price went nowhere on Thursday after the company reque...
Read ArticleIt’s late in the day on the 1st of December, which means not only is it 24 sleeps until Christmas, b...
Read ArticleClinical stage pharmaceutical cannabinoid and psychedelics company Incannex has engaged Eurofins to...
Read ArticleIncannex Healthcare (ASX: IHL) will begin manufacturing its ReneCann therapeutic for clinical trials...
Read ArticleIncannex Healthcare (IHL) engages Eurofins Scientific to manufacture IHL’s ReneCann product for skin...
Read ArticleIncannex is teaming with Eurofins to help people with opioid and nicotine addiction disorders, by un...
Read ArticleIncannex Healthcare (IHL) teams up with Luxembourg-based Eurofins Scientific to manufacture two chew...
Read ArticleClinical-stage pharmaceutical company Incannex Healthcare (ASX: IHL) has engaged French organisation...
Read ArticleThe Creso Pharma Ltd (ASX: CPH) share price is soaring 40% today. However, earlier, the company’s...
Read ArticleIncannex Healthcare (IHL) initiates a study to assess the effects and tolerability of its drug for o...
Read ArticleClinical-stage medicinal cannabis and psychedelic pharmaceutical company Incannex Healthcare (ASX: I...
Read ArticleASX cannabis shares havenât exactly been smoking hot this year. Thatâs partly because similar h...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price went up in smoke in October, underperforming the...
Read ArticleIt’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodge...
Read ArticleIncannex Healthcare (ASX: IHL) has made several advances across its portfolio of cannabinoid and psy...
Read ArticleGermany looks to legalise recreational cannabis and US and Canadian companies are paying attention ...
Read ArticleAmid a worldwide surge of interest in using psychedelic substances to treat stubborn mental health c...
Read ArticleAfter completing patient dosing in its Phase 1 clinical trial of anti-inflammatory IHL-675A, Incanne...
Read ArticleIncannex Healthcare (IHL) is gearing up to launch two second-phase clinical studies of its IHL-675A...
Read ArticleIncannex Healthcare (ASX: IHL) has completed the dosing of healthy volunteer participants in a phase...
Read ArticleIncannex Healthcare (IHL) completes a pre-investigational new drug application meeting with the US F...
Read ArticleClinical-stage pharmaceutical company Incannex Healthcare (ASX: IHL) has completed a pre-investigati...
Read ArticleASX cannabis shares have leapt back onto investor radars and are likely to grab more media headline...
Read ArticleHealthcare share Incannex Healthcare Ltd (ASX: IHL) was added to the S&P/ASX 300 Index (ASX: XK...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has been on a roll lately. It has rocketed 21.4%...
Read ArticleCambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has had a tough 2022, losing 50% of its value ye...
Read ArticleIncannex Healthcare has been promoted to the big league. Clinical stage pharmaceutical cannabinoid...
Read ArticleShares in Incannex Healthcare Ltd (ASX: IHL) roared higher to close the market on Monday. Incanne...
Read ArticleAt last the pot stocks are paying dividends. Not metaphorically either. Cronos Australia (ASX: CAU)...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has curled up in recent weeks, having bounced fr...
Read ArticleIncannex has appointed a former Pfizer and now Novo Nordisk A/S executive to its board to help steer...
Read ArticleASX cannabis shares have been mixed performers on the market in the year to date, but are there bet...
Read ArticleIncannex Healthcare (ASX: IHL) has appointed experienced pharmaceutical executive Robert B. Clark to...
Read ArticleIce-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm le...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has jumped from the opening gate on Tuesday. A...
Read ArticleASX cannabis share Incannex Healthcare Ltd (ASX: IHL) has caught a bid last week, reversing off 52...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a high. A...
Read ArticleShareCafeLunch Report: 5 August, 2022 by Tim McGowen Gold stocks are stronger across the board as...
Read ArticleIncannex Healthcare (ASX: IHL) now officially owns the world’s largest portfolio of patented medicin...
Read ArticleIncannex Healthcare (IHL) finalises its $125 million acquisition of APIRx Pharmaceuticals Stakehold...
Read ArticleThe ASX is set to open higher on Friday Wall Street was mixed overnight ahead of the US non-farm pa...
Read ArticleLeading Australian medicinal cannabis company Incannex (ASX: IHL) has today completed the acquisitio...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has bounced from 52-week lows today and now trad...
Read ArticleIncannex has moved to advance its inhaled drug product for the treatment of traumatic brain injury w...
Read ArticleIncannex Healthcare (IHL) engages research, development and manufacturing organisation Curia Global...
Read ArticleIncannex Healthcare (ASX: IHL) has announced it has engaged contract research, development, and manu...
Read ArticleMysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS n...
Read ArticleIt’s quarterlies season as the ASX market announcements page becomes increasingly flooded with lodge...
Read ArticleClinical-stage pharmaceutical company Incannex Healthcare (ASX: IHL) has provided an extensive updat...
Read ArticleIn the June quarter, Incannex Healthcare (IHL) progressed several clinical trials ahead of submitti...
Read ArticleHighlights The ASX 200 ended in the red after trading on a weak note for most part of the sess...
Read ArticleIncannex Healthcare (ASX: IHL) has collared ethics approval, which was the final regulatory hurdle b...
Read ArticleThe All Ordinaries Index (ASX: XAO) is wobbling today, jumping from red to green. Right now, the i...
Read ArticleIncannex Healthcare (IHL) receives ethics approval for a phase one clinical trial of its cannabinoi...
Read ArticleIncannex has achieved approval to start a milestone clinical trial into its multi-use, anti-inflamma...
Read ArticleThe ASX will open lower this morning despite a mini rally on Wall Street Tesla’s Q2 result was a su...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleThe ASX cannabis sector had its growth clipped in FY22 with plenty of shares declining in the finan...
Read ArticleThere were mixed fortunes for ASX cannabis shares in FY22. Among the bunch there were winners and l...
Read ArticleASX 200 healthcare shares were defensive in June but finished the month down overall. The benchmar...
Read ArticleThe S&P/ASX All Ordinaries Index (ASX: XAO) slipped 9.6% over the month of June. Negative sent...
Read ArticleShareCafeEvening Report: 3 June, 2022 by Lauren Evans The Australian sharemarket closed higher for...
Read ArticleIncannex Healthcare [ASX:IHL] climbed as high as 13% on Friday after releasing a clinical trials upd...
Read ArticleIncannex Healthcare (IHL) completes the phase two trial of its cannabinoid combination drug IHL-42X...
Read ArticleIncannex Healthcare (ASX: IHL) has found its drug IHL-42X reduced the apnoea hypopnea index (AHI) sc...
Read Article03 June 2022 - A snapshot of the stocks on the move featuring Healius (ASX:HLS), Incannex (ASX:IHL)...
Read ArticleShareCafeLunch Report: 3 June, 2022 by Melissa Darmawan The Australian sharemarket jumped at the o...
Read ArticleHealius releases trading update Incannex reports positive Phase 2 results Healthcare services prov...
Read ArticleActor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wel...
Read ArticleIn another significant milestone, Incannex Healthcare (ASX:IHL) says it’s received positive feedback...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is soaring during mid-afternoon trade. This foll...
Read ArticleClinical-stage cannabinoid pharmaceutical development company Incannex Healthcare (ASX: IHL) has com...
Read ArticleIncannex Healthcare (IHL) has met with the FDA to discuss its Pre-Investigational New Drug Applicat...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form again and tumbling lower. A...
Read ArticleIncannex Healthcare (ASX: IHL) has completed the share sale and purchase agreement to acquire APIRx...
Read ArticleIncannex shares have rocketed higher today on news it has signed a formal deal to buy out APIRx and...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is on the move today following a company’s lates...
Read ArticleRace Oncology is set to commence Phase 1 study of Zantrene after being given governance approval Rh...
Read ArticleIncannex Healthcare (IHL) signs a business deal to buy US-based APIRx Pharmaceuticals in an all-scr...
Read ArticleIHL’s novel drug IHL-216A could be the holy grail in concussion treatment, with promising preclinica...
Read ArticleHighlights The benchmark ASX 200 index tanked 2% to 6,978.6 in the first 15 minutes of trading....
Read ArticleIncannex Healthcare (IHL) announces positive findings from a preclinical study trialling its IHL-21...
Read ArticleClinical stage pharmaceutical company Incannex Healthcare (ASX: IHL) has confirmed its drug candidat...
Read ArticleShares of Incannex Healthcare Ltd (ASX: IHL) are on ice today pending a company announcement. Befo...
Read ArticleIncannex Healthcare (ASX: IHL) has released its March quarter (Q3 FY2022) results this week, unveili...
Read ArticleThe company had a busy quarter of clinical research breakthroughs, listing on NASDAQ and making a pl...
Read ArticleIncannex Healthcare (IHL) raises $23.6 million from investors to boost funding for its clinical tri...
Read ArticleWhile it hasn’t been immune to the big reset in Aussie markets, the cannabis sector has certainly r...
Read ArticleHighlights Biotechnology companies research living organisms to develop drugs and other products...
Read ArticleThe ACIC says weed consumption increased in cities and regions ROO receives USA design patent appro...
Read ArticleHighlights Incannex has executed a term sheet to wholly acquire APIRx Pharmaceutical USA APIRx...
Read ArticleASX Emerging Companies (XEC) index has closed 0.8% lower on Thursday Monday winners: Australian Van...
Read ArticleIncannex Healthcare (IHL) completes its acquisition of APIRx Pharmaceutical, a biotechnology compan...
Read ArticleMelbourne-based pharmaceutical company Incannex (ASX: IHL) is in a US$93.3 million (AUD$124 million)...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is having a tough time this morning. It sunk 7%...
Read ArticleIncannex Healthcare (ASX: IHL) has announced a deal to acquire APIRx Pharmaceutical USA in an all sc...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price won’t be going anywhere on Tuesday. This comes a...
Read ArticleShares in Incannex Healthcare Ltd (ASX: IHL) are pushing higher today and now trade almost 5% in th...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is wobbling today following a company announceme...
Read ArticleMedical cannabis company Incannex Healthcare Limited (IHL) plans a loyalty issue of options to all...
Read ArticleThe medicinal cannabis and psychedelic clinical development company has achieved a significant miles...
Read ArticleHighlights Incannex’s preliminary assessment of proof-of-concept trial data has indicated effica...
Read ArticleIncannex Healthcare (ASX: IHL) has completed a preliminary analysis of data from a phase 2 proof-of-...
Read ArticleIncannex Healthcare (IHL) sees a substantial reduction in obstructive sleep apnoea during clinical...
Read ArticleLike my brave suburb near the airport, the ASX 200 is sinking on Tuesday. Only, the XJO is down arou...
Read ArticleAs energy continues to steal the market spotlight, Incannex Healthcare Ltd [ASX:IHL] is enduring a m...
Read ArticleClinical-stage medicinal cannabis and psychedelic pharmaceutical company Incannex Healthcare (ASX: I...
Read ArticleIncannex Healthcare (IHL) executes a license agreement with Monash University to develop an anxiety...
Read ArticleThe ASX 200 Health Index (XHJ) is trading lower by 0.30% at the time of writing, compared to the bro...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleClinical-stage medical cannabis and psychedelic pharmaceutical company Incannex Healthcare (ASX: IHL...
Read ArticleThe bell has rung on Incannex’s much anticipated Nasdaq listing with the company hoping to attract k...
Read ArticleMelbourne-based medicinal cannabis product developer Incannex (ASX: IHL) has officially landed on th...
Read ArticleMedicinal cannabis developer, Incannex Healthcare (IHL) debuts on the Nasdaq trading under ticker c...
Read ArticleWith a share price that has risen ~65% in the past year, a recent merger with CDA Health and turning...
Read ArticleClinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has spent the Decem...
Read ArticleASX cannabis shares were a mixed bag in 2021 with the broad sector showing weakness across the enti...
Read ArticleShares in medicinal cannabis company Incannex Healthcare Ltd (ASX: IHL) chugged along nicely on Tue...
Read ArticleShares in the ASX cannabis sector have had another difficult time in December, as most majors come...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleThe Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product s...
Read ArticleWith Phase 2 dosing complete, IHL now prepares to file a pre-IND meeting application with the US Foo...
Read ArticleParticipants in Incannex Healthcare’s (IHL) phase two, proof-of-concept clinical study testing a ne...
Read ArticleThe ASX 200 Health Index (XHJ) is trading higher by 0.92% at the time of writing, compared to the br...
Read ArticleCannabinoid and psychedelics biotech Incannex Healthcare (ASX: IHL) has completed dosing of particip...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is in the red today after a company update on it...
Read ArticleIncannex Healthcare (ASX: IHL) has announced it is targeting a public offering and Nasdaq listing of...
Read ArticleMedicinal cannabis business Incannex Healthcare (IHL) is finalising its US Public Offering and gett...
Read ArticleThe ASX 200 Health Index (XHJ) is trading flat at the time of writing, compared to the broader index...
Read ArticleASX cannabis shares had a difficult month in November, with most majors finishing deep in the red....
Read ArticleThe S&P/ASX 200 Health Care index (ASX: XHJ) pared its October gains in November. The index wen...
Read ArticleShares in medicinal cannabis company Incannex Healthcare Ltd (ASX: IHL) are edging lower and now tr...
Read ArticleInstead of a chocolate advent calendar this year, Californians can get their hands on a cannabis cal...
Read ArticleASX cannabis shares were nothing short of a mixed bag last month. Several names did well but a larg...
Read ArticleMoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and...
Read ArticleHighlights Despite going through a rough patch, few ASX shares have gained over 400% from the p...
Read ArticleIncannex Healthcare (IHL) spikes on the ASX today after landing important regulatory approvals to t...
Read ArticlePsychedelic and cannabinoid biotech company Incannex Healthcare (ASX: IHL) has received ethics appro...
Read ArticleThe ASX 200 Health Index (XHJ) is up by 1.2% at the time of writing, compared to the broader index w...
Read ArticleIncannex Healthcare (IHL) has engaged Procaps S.A. to manufacture its soft-gel capsules in preparat...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is gaining ground in early trade today and is cu...
Read ArticleCannabinoid and psychedelic biotech company Incannex Healthcare (ASX: IHL) has engaged pharmaceutica...
Read ArticleTurn on, tune in and don’t drop out. The push to develop psychedelic drugs is gaining momentum, but...
Read ArticleClinical-stage cannabinoid and psychedelics medicine developer Incannex Healthcare (ASX: IHL) has an...
Read ArticleAs we make our way through the first half of FY22, equity markets have begun to shake up somewhat i...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has taken a beating over the past four weeks, ha...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has been a winner on the ASX over the last few w...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is having a year to remember. At the time of wri...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleVirginia is the latest US state to legalise marijuana and they’re celebrating with the first annual...
Read ArticleIncannex lodged extensive registration form with SEC. A strategic dual-listing will give Incannex ac...
Read ArticleLocal pot stock Incannex Healthcare [ASX:IHL] is in traders’ sights today. The stock shares is curre...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is on the move in afternoon trade after the comp...
Read ArticleClinical-stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has filed a registr...
Read ArticleHighlights Incannex Healthcare has filed a registration statement for a planned IPO (initial pub...
Read ArticleMassachusetts based cannabis operator MariMed has just announced a joint collaboration with the lege...
Read ArticleThe ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader index which...
Read ArticleClinical-stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has completed a Hum...
Read ArticleWall Street mixed as oil and metals fall US stock markets were mixed on Monday, as oil prices fell t...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price has remained flat in this morning’s trade, witho...
Read ArticleSpecial Report: Along with Phase 1 trials for IHL-675A, the company also received a positive respons...
Read ArticleClinical stage cannabinoid and psychedelic medicine development company Incannex Healthcare (ASX: IH...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price stormed 5.45% higher to 29.5 cents after resumin...
Read ArticleIHL is on track to obtain clinical results from its Phase 2b trial in the second half of this year....
Read ArticleClinical stage cannabinoid and psychedelic development company Incannex Healthcare (ASX: IHL) has fi...
Read ArticleThe ASX Healthcare index rose by 0.45% this morning, compared with the broader index which fell by 0...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price won’t be going anywhere today. Shares in the e...
Read ArticleThe Incannex Healthcare [ASX:IHL] share price rose 5.5% in early trade after IHL engaged a firm to m...
Read ArticleThe Incannex Healthcare [ASX:IHL] share price rose 5.5% in early trade after IHL engaged a firm to m...
Read ArticleIncannex has engaged Procaps to develop and manufacture its IHL-675A soft-gel capsules in preparatio...
Read ArticleWall Street mixed as F45 makes US IPO debut There was no clear direction in US equities markets over...
Read ArticleSpecialised pharmaceutical manufacturer Procaps SA has been engaged by Incannex Healthcare (ASX: IHL...
Read ArticleThe company now has a targeted research pathway to clinical success, with strong proprietary protect...
Read ArticleSummary The ASX 200 closed sharply lower by 133.60 points or 1.81% at 7,235.30. The market witn...
Read ArticleThe deal gives IHL a global partner to develop the drug and navigate the global regulatory backdrop....
Read ArticleCannabinoid development company Incannex Healthcare (ASX: IHL) has announced it has engaged drug man...
Read ArticleWall Street plummets on ‘Triple Witching day’ All major US indices fell on Friday, mostly on inflati...
Read ArticleLast week the US government announced it would begin granting growing approvals to several companies...
Read ArticleThe company has partnered with one of Australia’s leading sleep science research as the second test...
Read ArticleClinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has engaged the Uni...
Read ArticleTech stocks fell hard on the eve of US CPI report All major indices fell overnight on inflation fear...
Read ArticleIn a historic first, a medicinal cannabis drug has been listed on Australia’s Pharmaceutical Benefit...
Read ArticleThe Incannex share price was up 3.5%. The Incannex Healthcare Ltd [ASX:IHL] advanced its clinical t...
Read ArticleSummary Neuren Pharmaceuticals obtained a Canadian patent grant for trofinetide, with a patent t...
Read ArticleThe company is moving from strength to strength as it builds out its drug development pathway for th...
Read ArticleSummary Oventus Medical witnessed growth in booked revenue and acceleration in telehealth bookin...
Read ArticleThe US cannabis market reacted in jubilation last week, after the Secure and Fair Enforcement (SAFE)...
Read ArticleIncannex provides investors the best of breed for medicinal cannabis and psychedelic therapy develop...
Read ArticleASX pot stocks have run hot in recent months but eight in particular have been particularly rewardin...
Read ArticleApril 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually l...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is in reverse during late-afternoon trade. This...
Read ArticlePharmaceutical cannabis and psychedelic medicine company Incannex Healthcare (ASX:IHL) continues to...
Read ArticleClinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has held a pre-inve...
Read ArticleSummary Exopharm obtained firm commitments from institutional and sophisticated investors to rai...
Read ArticleThe mere mention of magic mushrooms, ecstasy or ketamine is enough to send parents of teenagers into...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) is making steady progress on its hydroxychloroquine (H...
Read ArticleThe pharmaceutical development company, Incannex Healthcare Ltd [ASX:IHL] share price is up after an...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is climbing on the back of a positive update reg...
Read ArticleIncannex Healthcare (ASX: IHL) will confer with the United States Food and Drug Administration after...
Read ArticleCannabis stock Bod Australia (ASX:BDA) has entered the fight against what is known as “long-COVID”....
Read ArticleIncannex Healthcare share price [ASX:IHL] is up today after its ASX update shows positive results fr...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) hydroxychloroquine/cannabidiol (CBD) cocktail is turni...
Read ArticleSource: Chinnapong,Shutterstock Summary Clinical stage pharmaceutical development player Incann...
Read ArticleIncannex Healthcare Ltd (ASX: IHL) shares are up again today as the company announced its new CBD-b...
Read ArticlePositive results from an in vivo study model using Incannex Healthcare’s (ASX: IHL) lead candidate I...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price, which has shot up 310% in the past 12 months, h...
Read ArticleIncannex Healthcare (ASX: IHL) has revealed it will work with Monash Trauma Group on an “extensive”...
Read ArticleShares trading in medicinal cannabinoid producer Incannex Healthcare Ltd [ASX:IHL] share price are f...
Read ArticleCOVID-19 vaccines have reached Australia but ASX stocks that were making anti-COVID 19 drugs or test...
Read ArticleBiotechnology company Greenlab Australia has secured a two-year deal to supply pharmaceutical-grade,...
Read ArticleThe share price of Incannex Healthcare Ltd (ASX:IHL) is up a further 15.9%, trading at 25.5 cents....
Read ArticleThe Incannex Healthcare Limited (ASX: IHL) share price has hit a 5-year high at 29 cents during ear...
Read ArticleSummary Incannex Healthcare disclosed promising anti-inflammatory properties of IHL-675A for IBD...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) has found a fifth possible use for its hydroxychloroqu...
Read ArticleIncannex Healthcare (ASX: IHL) has been buoyed by the potential of its candidate IHL-675A to become...
Read ArticleIncannex Healthcare (ASX: IHL) has been buoyed by the potential of its candidate IHL-675A to become...
Read ArticleThe Incannex Healthcare Ltd (ASX: IHL) share price is soaring today as the company announced that i...
Read ArticleMedicinal cannabinoid company Incannex Healthcare Ltd [ASX:IHL] is one of the leading stocks. At tim...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) has announced it will explore a dual listing in the Un...
Read ArticleNews that an Austrian hospital using medical cannabis to treat patients with COVID-19 has yielded po...
Read ArticleASX-listed cannabinoid stocks are poised for a resurgence after global biopharmaceutical company Jaz...
Read ArticleThe Incannex Healthcare Limited (ASX: IHL) share price has zoomed up today as the company announced...
Read ArticleSummary Cannabinoid medicines manufacturer Incannex Healthcare has received positive outcomes fr...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) shares have gained after the pharmaceutical developmen...
Read ArticleClinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has received positi...
Read ArticleThe December 2020 quarter heralded Incannex Healthcare’s (ASX: IHL) fifth consecutive period of reco...
Read ArticleSummary Incannex Healthcare is engaged in developing pharmaceutical products with significant ec...
Read ArticleOn a path to developing a suite of cannabinoid-based medicines aimed at remedying a range of debilit...
Read ArticleSummary Incannex Healthcare disclosed positive outcomes for the neuroprotective capability of IH...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) has flagged positive results from its study on brain-d...
Read ArticleIncannex Healthcare (ASX: IHL) has revealed more positive in vivo research for its IHL-216A drug, th...
Read ArticleAt time of writing, the share price of Incannex Healthcare Ltd [ASX:IHL] is up more than 20%, tradin...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) is partnering with Monash University for a rigorous sc...
Read ArticleSummary Incannex Healthcare and Monash University has signed a partnership agreement to perform...
Read ArticleIncannex Healthcare (ASX: IHL) has partnered with Monash University to undertake a “world first” cli...
Read ArticleCannabis and its derivatives are on their way to being more widely recognised for their medicinal an...
Read ArticleASX large cap biotech Mesoblast (ASX:MSB) is not alone in fighting Acute Respiratory Distress Syndro...
Read ArticleSpecial Report: Medical cannabis company Incannex Healthcare (ASX:IHL) says a mice study has further...
Read ArticleCannabinoid development company Incannex Healthcare (ASX: IHL) has unveiled the latest test results...
Read ArticleCannabinoid drug development company Incannex Healthcare (ASX: IHL) could be on the cusp of announci...
Read ArticleIt’s been a big night for pot stocks in the US. With a nail-biting election that could dramatically...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) says its hydroxychloroquine/cannabidiol combination dr...
Read ArticleClinical-stage cannabinoid development company Incannex Healthcare (ASX: IHL) has received positive...
Read ArticleSummary Audio Pixels Holdings (ASX:AKP) is bringing new technologies to digital loudspeaker techn...
Read ArticleNew changes to medicinal cannabis announced by Australia’s drug regulator last month are more about...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) has reported its best quarter to date from the sales o...
Read ArticleThe Incannex Healthcare Ltd [ASX:IHL] share price has risen 6.17% today, to trade at 8.6 cents at th...
Read ArticleIncannex (ASX: IHL) has reported its highest period of sales for the September period – beating its...
Read ArticleThe number of new patients trying medicinal cannabis for the first time has risen significantly sinc...
Read ArticleSpecial Report: Incannex Healthcare (ASX:IHL) has received ethics approval to begin a clinical trial...
Read ArticleIncannex Healthcare (ASX: IHL) has received ethics approval for a phase 2b clinical trial to study t...
Read ArticleIn a move that would appear to enthuse the ASX-listed cannabis stocks, the Therapeutic Goods Adminis...
Read ArticleClinical-stage cannabinoid development company Incannex Healthcare (ASX: IHL) has announced positive...
Read ArticleCannabinoid development company Incannex Healthcare (ASX: IHL) has commenced a pre-clinical animal t...
Read ArticleFrom the low in April 2020, the share price has moved up over 138% to where it is today, all this on...
Read ArticleMedicinal cannabis company Incannex Healthcare (ASX:IHL) says mice testing for its cannabidiol treat...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleAfter reporting amiable progress concerning its sleep apnoea drug IHL-42X just last week, cannabinoi...
Read ArticleClinical stage cannabinoid development company Incannex Healthcare (ASX: IHL) has partnered with The...
Read ArticleMoney is coming in for marijuana companies, as Bod Australia (ASX:BOD) leads the total today with ne...
Read ArticleCannabinoid development company Incannex Healthcare (ASX: IHL) has published provisional performance...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) has announced it will discontinue sales of...
Read ArticleImpression Healthcare (ASX: IHL) has begun the first clinical trial to assess the effectiveness of i...
Read ArticleLast year was a solid year for many ASX stocks and 2020 was also looking pretty good until COVID-19...
Read ArticleNorth American pot stocks are roaring back from lows in March but the same cannot be said for their...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) has unveiled a high profile acquisition in...
Read ArticleImpression Healthcare (ASX: IHL) has confirmed in it quarterly report that it has sourced all permit...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) has confirmed plans to bring its novel can...
Read ArticleIn many cases COVID-19 causes only mild symptoms. But when it is deadly and requires patients to use...
Read ArticleMedicinal cannabis company Impression Healthcare (ASX: IHL) has developed a cannabidiol (CBD) based...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) has revealed it has received an independen...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) came out of a trading halt late this morni...
Read ArticleAustralian medical cannabis company Impression Healthcare (ASX: IHL) has taken yet another assertive...
Read ArticleAustralian medical cannabis company Impression Healthcare (ASX: IHL) has finalised the design of a c...
Read ArticleThere are ASX small caps addressing brain problems and stocks seeking to test cannabis for medicinal...
Read ArticleImpression Healthcare (ASX:IHL) is boosting its stock of medicinal cannabis products to “ensure ongo...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) has expanded its cannabinoid oil sales pro...
Read ArticleWith the health and life science sector being the ASX’s top performer last year, Western Australia i...
Read ArticleImpression Healthcare (IHL) has received all permits needed to begin a clinical trial in treating o...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) is on course to begin a clinical trial usi...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleCanadians rolled some big… notes last year after handing over $C1 billion ($1.5 billion) or $C24 a p...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) is continuing on its path to developing an...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleCannabis has been progressively decriminalised around the world since the early 2000s, starting with...
Read ArticleCannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the c...
Read ArticleMedical cannabis company Impression Healthcare (ASX: IHL) has continued its top-tier recruitment dri...
Read ArticleThere are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so...
Read ArticleIn the few short years since cannabis companies first floated on stock exchanges around the world, t...
Read ArticleDr Sud Agarwal presented at Impression Healthcare’s (ASX: IHL) annual general meeting on Friday 4th...
Read ArticleImpression Healthcare Limited (ASX: IHL) has filed a patent application covering IHL-216A. IHL-216A...
Read ArticleImpression Healthcare (ASX: IHL) has opted to file a patent application for a neuroprotective agent...
Read ArticleDespite the Australian government approving the use of cannabis for medical purposes close to three...
Read ArticleFollowing a busy few months on the recruitment and brand licensing fronts, Impression Healthcare (AS...
Read ArticleTHC Global (ASX:THC) has secured 18 hectares of agricultural land and 6.6 hectares of existing hydro...
Read ArticleImpression Healthcare (ASX: IHL) has bolstered its Medical Advisory Board by appointing two leading...
Read ArticleImpression Healthcare (ASX: IHL) has added further weight to its broad-based position within the med...
Read ArticleThe legalisation of medical cannabis in southeast Asia is gathering steam with news that Thailand ha...
Read ArticleAustralia has a well-regulated and high-quality health sector, while its medical research and health...
Read ArticleFollowing last week’s deal that saw Impression Healthcare (ASX: IHL) secure the cannabinoid material...
Read ArticleOn 9 August 2019, the Australian Benchmark index S&P/ASX 200 closed at 6,584.4, up by 16.30 poin...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleImpression Healthcare (ASX: IHL) has moved to extend its medicinal cannabis market coverage after un...
Read ArticleOn Stockhead today – the final wrap from Diggers and Dealers, the feds are finally on board with leg...
Read ArticleThe federal government has taken steps to cut red tape and speed up the granting of licences for Aus...
Read ArticleOn Stockhead today – mining lithium from seawater, our monthly dairy stocks update, and why Hot Copp...
Read ArticleMedicinal cannabis company Cannvalate is getting its ducks in a row ahead of its planned IPO, streng...
Read ArticleBarely a week after Aurora announced a deal with the Ultimate Fighting Championship (UFC), Australia...
Read ArticleData analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($5...
Read ArticleSince the ASX is flooded with quarterlies, we’ve summarised a list of the five health companies that...
Read ArticleOne of the world’s largest cannabis companies and the world’s premier mixed martial arts organisatio...
Read ArticleImpression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a...
Read ArticleTaking the cannabis market to the next level, the US is now taking a closer look at the industry’s l...
Read ArticleImpression Healthcare (ASX: IHL) has extended the global coverage of its Fitguard by Gameday concuss...
Read ArticleThe relative strength index (RSI) is an important technical indicator for stock traders. It provides...
Read ArticleCalifornian cannabis company Caliva has signed on billionaire rapper Shawn “Jay-Z” Carter to promote...
Read ArticleWth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis...
Read ArticleAustralia is home to some of the top physicians as well as healthcare professionals. For more than 3...
Read ArticleImpression Healthcare (ASX: IHL) is on the brink of conducting a sleep apnoea trial with its own var...
Read ArticleImpression Healthcare (ASX: IHL) has unveiled a brand-new exclusive research and supply agreement th...
Read ArticleThis week the US state of Illinois became the first to pass a bill allowing retail sales of recreati...
Read ArticleImpression Healthcare’s (ASX: IHL) “world first” clinical trial using its cannabidiol (CBD)-based mo...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
